Completed
QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors
NCT01106248
- Conditions
- Advanced Solid Tumor, Neoplasms
- Locations
-
- Medicale Dunkirk, *CS, France
- Service d'Oncologie Dunkirk, *CS, France